Searching for the hereditary causes of renal-cell carcinoma

被引：140

作者：

Pavlovich, CP

Schmidt, LS

机构：

[1] Johns Hopkins Bayview Med Ctr, Brady Urol Inst, Baltimore, MD 21224 USA

[2] NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA

来源：

NATURE REVIEWS CANCER | 2004年 / 4卷 / 05期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrc1364

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Families with hereditary predispositions to cancer continue to provide a unique opportunity for the identification and characterization of genes involved in carcinogenesis. A surprising number of genetic syndromes predispose to the development of renal-cell carcinoma, and already genes associated with five of these syndromes have been identified - VHL, MET, FH, BHD and HRPT2. These very different genes and the biochemical pathways in which they participate raise interesting questions about the development of renal cancers and could lead to new therapeutic approaches in the near future. So, what is known about hereditary renal cancer at present?

引用

页码：381 / 393

页数：13

共 173 条

[21]

CHEN F, 1995, CANCER RES, V55, P4804

[22] GERMLINE MUTATIONS IN THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE - CORRELATIONS WITH PHENOTYPE [J].

CHEN, F ;

KISHIDA, T ;

YAO, M ;

HUSTAD, T ;

GLAVAC, D ;

DEAN, M ;

GNARRA, JR ;

ORCUTT, ML ;

DUH, FM ;

GLENN, G ;

GREEN, J ;

HSIA, YE ;

LAMIELL, J ;

LI, H ;

WEI, MH ;

SCHMIDT, L ;

TORY, K ;

KUZMIN, I ;

STACKHOUSE, T ;

LATIF, F ;

LINEHAN, WM ;

LERMAN, M ;

ZBAR, B .

HUMAN MUTATION, 1995, 5 (01) :66-75

[23] The t(1;3) breakpoint-spanning involved in clear cell renal cell genes LSAMP and NORE1 are carcinomas [J].

Chen, JD ;

Lui, WO ;

Vos, MD ;

Clark, GJ ;

Takahashi, M ;

Schoumans, J ;

Khoo, SK ;

Petillo, D ;

Lavery, T ;

Sugimura, J ;

Astuti, D ;

Zhang, C ;

Kagawa, S ;

Maher, ER ;

Larsson, C ;

Alberts, AS ;

Kanayama, HO ;

Teh, BT .

CANCER CELL, 2003, 4 (05) :405-413

[24] Mutations in the met oncogene unveil a "dual switch" mechanism controlling tyrosine kinase activity [J].

Chiara, F ;

Michieli, P ;

Pugliese, L ;

Comoglio, PM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :29352-29358

[25] Rising incidence of renal cell cancer in the United States [J].

Chow, WH ;

Devesa, SS ;

Warren, JL ;

Fraumeni, JF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1628-1631

[26] Imaging of hereditary renal cancer [J].

Choyke, PL .

RADIOLOGIC CLINICS OF NORTH AMERICA, 2003, 41 (05) :1037-+

[27] Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease [J].

Clifford, SC ;

Cockman, ME ;

Smallwood, AC ;

Mole, DR ;

Woodward, ER ;

Maxwell, PH ;

Ratcliffe, PJ ;

Maher, ER .

HUMAN MOLECULAR GENETICS, 2001, 10 (10) :1029-1038

[28] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein [J].

Cockman, ME ;

Masson, N ;

Mole, DR ;

Jaakkola, P ;

Chang, GW ;

Clifford, SC ;

Maher, ER ;

Pugh, CW ;

Ratcliffe, PJ ;

Maxwell, PH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25733-25741

[29] HEREDITARY RENAL-CELL CARCINOMA ASSOCIATED WITH A CHROMOSOMAL TRANSLOCATION [J].

COHEN, AJ ;

LI, FP ;

BERG, S ;

MARCHETTO, DJ ;

TSAI, S ;

JACOBS, SC ;

BROWN, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (11) :592-595

[30] Pathway specificity for Met signalling [J].

Comoglio, PM .

NATURE CELL BIOLOGY, 2001, 3 (07) :E161-E162

← 1 2 3 4 5 6 7 8 9 10 →